1. Home
  2. Laboratory Improvement
  3. Proficiency Testing
  4. SARS-CoV-2 Proficiency Testing Programs

SARS-CoV-2 Proficiency Testing Programs

As laboratories expand patient testing capabilities for detection of or exposure to the novel coronavirus (SARS‑CoV‑2), we have introduced new proficiency testing (PT) programs to support your efforts.

Enroll Today

Place your order today to ensure material availability.

Order SARS-CoV-2 Serology (COVS) Right Arrow Order SARS-CoV-2, Molecular (COV2) Right Arrow

Inspired by Your Resourcefulness and Dedication to Accuracy

As you adapt to a rapidly changing testing landscape, we are here to support you with PT programs to meet your regulatory needs for COVID-19 testing.

The SARS‑CoV‑2, Molecular (COV2) PT program is intended for laboratories performing nucleic acid amplification tests to detect the novel coronavirus. The SARS‑CoV‑2 Serology (COVS) PT program is designed for laboratories performing serology testing to detect the presence of antibodies against the SARS‑CoV‑2 virus.

Refer to our clarifying tests for COVID-19 table to determine which method is appropriate for your laboratory’s needs.

SARS‑CoV‑2, Molecular (COV2)

Program Benefits

Enrolling in our COV2 program can help your laboratory:

  • Add a level of quality assurance to your molecular testing ensuring you deliver accurate, reliable test results to diagnose COVID-19
  • Enable your laboratory to assess your entire workflow from nucleic acid extraction through detection
  • Meet requirements for assessing the quality of your assay at least twice per year

Program Details

Program Ordering CodeCOV2
Testing typeNucleic acid amplification
Specimen description1.5-mL non-infectious liquid specimens that contain the whole SARS-CoV-2 genome
Gene targetsProvides sequence targets across all assay platforms
Specimens per shipment3
Shipments per year2
2020 shipment datesMay 18; November 16

SARS‑CoV‑2 Serology (COVS)

Program Benefits

Enrolling in our COVS program can help your laboratory:

  • Evaluate the accuracy of antibody testing—report results for qualitative and quantitative methods for total, IgG, IgM and IgA antibodies
  • Detect potential issues in your antibody testing using donor-based serum PT specimens that are clinically relevant and mimic patient testing
  • Meet requirements for assessing the quality of your assay at least twice per year

Program Details

Program Ordering CodeCOVS
Antibodies detectedTotal, IgG, IgM, and IgA antibodies to SARS‑CoV‑2
Testing typeSerology testing/Antibody testing
Method compatibilityCompatible with most testing platforms
Specimen description0.5 -mL non-infectious, donor-based serum specimens
Specimens per shipment3
Shipments per year2
2020 shipment datesJune 22; November 9